ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2012

Potential role of linagliptin as an oral once-daily treatment for patients with type 2 diabetes.

Lene Hoimark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.